help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeyakumar, M.
Right arrow Articles by Bagchi, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeyakumar, M.
Right arrow Articles by Bagchi, M. K.
Molecular Endocrinology 11 (6): 755-767
Copyright © 1997 by The Endocrine Society

Analysis of the Functional Role of Steroid Receptor Coactivator-1 in Ligand-Induced Transactivation by Thyroid Hormone Receptor

M. Jeyakumar, Michael R. Tanen and Milan K. Bagchi

The Population Council and The Rockefeller University, New York, New York 10021

The nuclear hormone receptors belonging to the steroid/thyroid/retinoid receptor superfamily are ligand-inducible transcription factors. These receptors modulate transcription of specific cellular genes, either positively or negatively, by interacting with specific hormone response elements located near the target promoters. Recent studies indicated that the hormone- occupied, DNA-bound receptor acts in concert with a cellular coregulatory factor, termed coactivator, and the basal transcription machinery to mediate gene activation. Consistent with this scenario, a number of nuclear proteins with potential coactivator function have been isolated. In the present study, we demonstrate that steroid receptor coactivator-1 (SRC-1), a recently isolated candidate coactivator, functions as a positive regulator of the thyroid hormone receptor (TR)-mediated transactivation pathway. In transient transfection experiments, coexpression of SRC-1 significantly enhanced ligand-dependent transactivation of a thyroid hormone response element (TRE)-linked promoter by human TRß. Our studies revealed that deletion of six amino acids (451–456) in the extreme COOH-terminal region of TRß resulted in a receptor that retained the ability to bind T3 but failed to be stimulated by SRC-1. These six amino acids are part of an amphipathic helix that is highly conserved among nuclear hormone receptors and contains the core domain of the ligand-dependent transactivation function, AF-2. In agreement with this observation, in vitro protein binding studies showed that SRC-1 interacted with a ligand binding domain peptide (145–456) of TRß in a T3-dependent manner, whereas it failed to interact with a mutant ligand binding domain lacking the amino acids (451–456). We demonstrated that a synthetic peptide containing the COOH-terminal amino acids (437–456) of TRß efficiently blocked the ligand-induced binding of SRC-1 to the receptor. These results suggest that the conserved amphipathic helix that constitutes the AF-2 core domain of TRß is critical for interaction with SRC-1 and thereby plays a central role in coactivator-mediated transactivation. We further observed that a heterodimer of TRß and retinoid X receptor-{alpha} (RXR{alpha}), either in solution or bound to a DR+4 TRE, recruited SRC-1 in a T3-dependent manner. The AF-2 of TR was clearly involved in this process because a TR-RXR heterodimer containing a mutant TRß (1–450) with impaired AF-2 failed to bind to SRC-1. Surprisingly, the RXR-specific ligand 9-cis-retinoic acid induced binding of SRC-1 to the RXR component of the TRE-bound heterodimer. This novel finding suggests that RXR, as a heterodimeric partner of TR, has the potential to play an active role in transcriptional regulation. Our results raise the interesting possibility that a RXR-specific ligand may modulate T3-mediated signaling by inducing additional interactions between TRE-bound TR-RXR heterodimer and the coactivator.




This article has been cited by other articles:


Home page
Circ. Res.Home page
R. Rouf, S. Greytak, E. C. Wooten, J. Wu, J. Boltax, M. Picard, E. C. Svensson, W. H. Dillmann, R. D. Patten, and G. S. Huggins
Increased FOG-2 in Failing Myocardium Disrupts Thyroid Hormone-Dependent SERCA2 Gene Transcription
Circ. Res., August 29, 2008; 103(5): 493 - 501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Ma, P. Freitag, J. Zhou, B. Brune, S. Frede, and J. Fandrey
Thyroid hormone induces erythropoietin gene expression through augmented accumulation of hypoxia-inducible factor-1
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R600 - R607.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev, July 1, 2001; 81(3): 1097 - 1142.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K.-h. Lin and Y.-h. Wu shen-liang chen
Impaired Interaction of Mutant Thyroid Hormone Receptors Associated with Human Hepatocellular Carcinoma with Transcriptional Coregulators
Endocrinology, February 1, 2001; 142(2): 653 - 662.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Resnick, D. A. Schreihofer, A. Periasamy, and M. A. Shupnik
Truncated Estrogen Receptor Product-1 Suppresses Estrogen Receptor Transactivation by Dimerization with Estrogen Receptors alpha and beta
J. Biol. Chem., March 15, 2000; 275(10): 7158 - 7166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. M. Sladek, M. D. Ruse Jr., L. Nepomuceno, S.-M. Huang, and M. R. Stallcup
Modulation of Transcriptional Activation and Coactivator Interaction by a Splicing Variation in the F Domain of Nuclear Receptor Hepatocyte Nuclear Factor 4alpha 1
Mol. Cell. Biol., October 1, 1999; 19(10): 6509 - 6522.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Alen, F. Claessens, G. Verhoeven, W. Rombauts, and B. Peeters
The Androgen Receptor Amino-Terminal Domain Plays a Key Role in p160 Coactivator-Stimulated Gene Transcription
Mol. Cell. Biol., September 1, 1999; 19(9): 6085 - 6097.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Kraichely, J. J. Collins III, R. K. DeLisle, and P. N. MacDonald
The Autonomous Transactivation Domain in Helix H3 of the Vitamin D Receptor Is Required For Transactivation and Coactivator Interaction
J. Biol. Chem., May 14, 1999; 274(20): 14352 - 14358.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. A. Schreihofer, E. M. Resnick, A. Y. Soh, and M. A. Shupnik
Transcriptional Regulation by a Naturally Occurring Truncated Rat Estrogen Receptor (ER), Truncated ER Product-1 (TERP-1)
Mol. Endocrinol., February 1, 1999; 13(2): 320 - 329.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. A. Onate, V. Boonyaratanakornkit, T. E. Spencer, S. Y. Tsai, M.-J. Tsai, D. P. Edwards, and B. W. O'Malley
The Steroid Receptor Coactivator-1 Contains Multiple Receptor Interacting and Activation Domains That Cooperatively Enhance the Activation Function 1 (AF1) and AF2 Domains of Steroid Receptors
J. Biol. Chem., May 15, 1998; 273(20): 12101 - 12108.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X. Zhang, M. Jeyakumar, S. Petukhov, and M. K. Bagchi
A Nuclear Receptor Corepressor Modulates Transcriptional Activity of Antagonist-Occupied Steroid Hormone Receptor
Mol. Endocrinol., April 1, 1998; 12(4): 513 - 524.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society